Respiratory Season Update: Abbott Labs
From acute infection to disease surveillance, rapid diagnostic COVID-19 tests remain a key strategy in mitigating disease transmission. Healthcare systems are being tasked with preparing for an uncertain respiratory season; influenza remains at large, RSV is sporadically appearing and the impact of variants on tests and vaccines remain an ever-present concern.
Dr. Moore, an expert in microbiology and infectious diseases, will discuss the latest guidance on rapid respiratory testing and co-infections during the respiratory season and provide an update on variant surveillance and diagnostic tests to include molecular to antigen testing. This session will focus on solutions that can be optimized in critical access settings.
The objectives for this webinar are:
- Discuss the upcoming respiratory season and the impact of COVID-19
- Evaluate use cases for different rapid respiratory testing methods, including molecular antigen assays
- Review current COVID-19 testing recommendations for symptomatic and asymptomatic use cases
- Describe COVID-19 variants and the impact of variants on diagnostic tests
